Liver Transplant for Liver Cancer: 2022 Liver Transplant Virtual CME Series

Penn Medicine's Peter L. Abt, MD, Surgical Director of the Liver Transplant Program, and Maarouf A. Hoteit, MD, Medical Director of the Liver Transplant Program and Director of the Liver Tumor Clinic, present session two of this year's Liver Transplant Virtual CME Series to share their perspectives on liver transplantation as an ideal treatment for early stage nonresectable hepatocellular carcinoma (HCC), review local regional therapy for down-staging of HCC tumors exceeding standard criteria for transplant, and offer insight on the selection criteria and treatment protocols for liver transplantation in cholangiocarcinoma, formerly an absolute contraindication to transplantation.

#PennMedicine #LiverTransplant #LiverCancer

• Loại